Briacell Therapeutics Corp (BCTX) Price Prediction & ForecastBCTXBriacell Therapeutics Corp

Alphio's BCTX stock price prediction model matches the current Briacell Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.97 (+0.57%). The 1-week path is $4.03 (+1.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Briacell Therapeutics Corp (BCTX) is not a good buy right now due to its significant financial losses and poor technical indicators. The current price is $3.09, which is down 56.90% year-to-date and 69.35% over the past year. The RSI is at 25.377, indicating that the stock is oversold, but the lack of revenue and consistent losses, such as a net income loss of -12,320,370 USD projected for Q4 2026, raises concerns about its viability. Additionally, the stock has a forward P/E of 0, reflecting uncertainty in future earnings, and the recent public offering at $3.25 per share has led to volatility, with a recent drop of 11.71% over the past five days. The main risk is the company's ongoing financial instability, as indicated by the negative EPS of -1.24 reported in the last earnings release.

Briacell Therapeutics Corp (BCTX) last closed at $3.95, gaining +20.80%. These facts feed the 1-day and 1-week BCTX price prediction above.